Lithium and Palpitations: Evaluation and Management
In a patient on lithium presenting with palpitations, immediately obtain a 12-lead ECG, check serum lithium level, and assess renal function, as lithium causes cardiac arrhythmias including sinus bradycardia, AV block, and can unmask Brugada syndrome even at therapeutic levels.
Immediate Evaluation
ECG Assessment - Critical First Step
Obtain a 12-lead ECG immediately to evaluate for:
- Sinus bradycardia (most common cardiac manifestation) 1, 2
- AV block of varying degrees 1
- T-wave abnormalities (flattening, isoelectricity, or inversion) 1
- Brugada pattern (ST-segment elevation in V1-V2) - lithium can unmask this potentially lethal syndrome even at therapeutic concentrations 3, 4
- QT interval changes (though reports are divergent) 5
Laboratory Workup
Draw blood for:
- Serum lithium level (stat) - toxicity risk increases above 1.5 mEq/L, though sensitive patients may show toxicity below this threshold 1
- Renal function (creatinine, BUN) - acute kidney injury is a common precipitant of lithium toxicity and cardiac manifestations 2
- Electrolytes - particularly sodium, as depletion increases lithium toxicity risk 1
Risk Stratification Based on Lithium Level
Therapeutic Range (0.6-1.2 mEq/L)
Even at therapeutic levels, lithium can cause:
- Benign sinus bradycardia 6
- T-wave changes 1
- Unmasking of Brugada syndrome 4 - lithium blocks cardiac sodium channels with an IC50 of 6.8 μmol/L, well below therapeutic range
Elevated Levels (>1.5 mEq/L)
Higher risk for:
Management Algorithm
If ECG Shows Significant Abnormalities:
Sinus Bradycardia with Hemodynamic Compromise:
- Hold lithium immediately 2
- Provide intravenous fluid resuscitation 2
- Consider transcutaneous pacing if symptomatic 2
- Consider inotropic support if hypotensive 2
- Monitor continuously until heart rate normalizes
Heart Block or Brugada Pattern:
- Discontinue lithium immediately 3, 7
- Continuous cardiac monitoring
- Cardiology consultation
- Consider hemodialysis if lithium level significantly elevated 8
- ECG changes typically reverse with lithium withdrawal 3, 7
If Renal Impairment Present:
This is a critical pitfall - renal dysfunction is the most common cause of chronic lithium toxicity 8:
- Aggressive IV hydration 2
- Consider hemodialysis for severe toxicity (lithium is readily dialyzable) 8
- Do NOT restart lithium until renal function normalizes
Medication Review
Evaluate for drug interactions that increase lithium levels:
- Diuretics - contraindicated with lithium due to high toxicity risk 1
- NSAIDs - reduce lithium clearance
- ACE inhibitors/ARBs - increase lithium levels
- Antiarrhythmic drugs - require caution 5
Common Pitfalls to Avoid
Assuming therapeutic levels are safe - cardiac toxicity, particularly Brugada unmasking, can occur at therapeutic concentrations 4
Missing volume depletion - lithium-induced nephrogenic diabetes insipidus causes volume depletion, which then increases lithium levels, creating a vicious cycle 8
Overlooking chronic toxicity - this is the most common pattern and often unintentional, presenting insidiously 8
Delaying lithium discontinuation - when significant cardiac conduction abnormalities are present, prompt discontinuation typically leads to rapid improvement, often avoiding need for permanent pacing 7
Disposition and Follow-up
Admit if:
- Symptomatic bradycardia or heart block
- Lithium level >1.5 mEq/L with cardiac symptoms
- Brugada pattern on ECG
- Acute kidney injury
- Any hemodynamic instability
Outpatient management acceptable if:
- Asymptomatic with benign ECG changes (mild T-wave flattening)
- Therapeutic lithium level
- Normal renal function
- Close follow-up arranged within 24-48 hours with repeat lithium level and ECG
The cardiac effects of lithium are under-recognized but potentially life-threatening 7. Maintaining a high index of suspicion and obtaining an ECG in any lithium patient with palpitations is essential, as early recognition and lithium discontinuation typically result in rapid clinical improvement 2, 7.